On June 12, 2026, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) director Brian P. McKeon executed a purchase of 10,000 shares of the company's common stock. The transaction was valued at $101,199, with each share acquired at a price of $10.12. This acquisition increases McKeon's existing stake in the dental technology firm.
Following this purchase, McKeon's ownership structure includes an indirect holding of 10,000 shares through a trust, alongside a direct position of 28,887 shares of common stock. The insider activity occurs while XRAY shares are trading close to their 52-week low of $9.40, reflecting a 33% decline over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels. Despite recent challenges, the company pays a significant 6.34% dividend yield and has maintained dividend payments for 32 consecutive years.
In other recent news, Dentsply Sirona reported mixed financial results for the first quarter of 2026. The company's revenue surpassed expectations, reaching $880 million compared to the forecasted $842.58 million. However, earnings per share fell slightly short, coming in at $0.27 against a projected $0.28. Needham maintained its Hold rating on Dentsply Sirona, citing execution risk despite the favorable revenue outcome. The firm noted that the company's earnings per share missed Street expectations by one cent.
Additionally, Dentsply Sirona announced an expanded partnership with Nashville Dental, set to begin in August 2026. This agreement will include the distribution of Dentsply Sirona's connected technology solutions across a nine-state territory. These developments reflect the company's ongoing efforts to enhance its market presence and product distribution.